Understanding of the mechanism of cutaneous scar formation with the goal of developing potential therapies to promote scar-less wound healing appears to be extremely critical. Mesenchymal stem cells (MSCs) have a demonstrate role in promoting scar-less wound healing. However, recent studies have shown that the function of MSCs may be attenuated due to insufficient activation in vivo. Here, we aimed to increase the activity and functions of MSCs to improve their effects during scar formation. We found that overexpression of microRNA-375 (miR-375) in MSCs significantly decreased the levels of tissue inhibitor of metalloproteinases 1 (TIMP-1) protein, but not mRNA. Mechanistically, miR-375 inhibited TIMP-1 protein translation through binding to the 3'-UTR of the TIMP-1 mRNA in MSCs. Transplantation of miR-375-expressing MSCs significantly reduced the fibrosis in the scar region of the mice, possibly through reduction of reactive oxygen species (ROS), suppression of transition of myofibroblasts from fibroblasts, and increases in hepatic growth factor (HGF). Together, these data suggest that overexpression of miR-375 in MSCs may substantially improve the effects of MSCs on reduction of scar during wound healing. Our study sheds new light on a scar-less wound healing.
基金:
Important Medical Funded Projects of Hebei Province Health Department [zd2013095]; Heibei Province Medical Follow-up Project
第一作者机构:[1]Chinese Peoples Liberat Army Gen Hosp, Coll Life Sci, Wound Care Ctr, Beijing 100853, Peoples R China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Sheng Wei,Feng Zihao,Song Qi,et al.Modulation of mesenchymal stem cells with miR-375 to improve their therapeutic outcome during scar formation[J].AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH.2016,8(5):2079-2087.
APA:
Sheng, Wei,Feng, Zihao,Song, Qi,Niu, Heyong&Miao, Guoying.(2016).Modulation of mesenchymal stem cells with miR-375 to improve their therapeutic outcome during scar formation.AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH,8,(5)
MLA:
Sheng, Wei,et al."Modulation of mesenchymal stem cells with miR-375 to improve their therapeutic outcome during scar formation".AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH 8..5(2016):2079-2087